The Riverside Company

News, insights, analysis and data

← Back to The Riverside Company profile

The Riverside Company related stories

All articles and analysis

  • Global invests in Turkish healthcare
    Toby Mitchenall- 5 January 2013

    Global Investment House has become the latest private equity firm to tap into the growing sector with the acquisition of Biçakcilar, a manufacturer of medical hardware.

  • NBGI inks debut Turkey deal
    Toby Mitchenall- 5 January 2013

    The European mid-market firm is set to unveil its first deal in Turkey – an investment in a healthcare provider – with another deal understood to be imminent.

  • Charterhouse in healthcare exit to Riverside
    Graham Winfrey- 5 January 2013

    The mid-market firm has exited its 2006 investment in Camelot, a behavioral health and alternative education company, in a deal estimated at under $100m.

  • PEC adds 18 members, changes name
    Jenna Gottlieb- 5 January 2013

    The Washington, DC trade group has more than doubled its membership to include mid-market firms, and has created a committee to consider issues relating to the small and mid-market.

  • Texas ERS may cut PE allocation by $100m
    Christopher Witkowsky- 5 January 2013

    The $20bn US pension is also considering carving out a new allocation for debt investments.

  • Riverside does first Turkish deal
    Amanda Janis- 5 January 2013

    The global mid-market firm is the latest attracted to Turkish companies, having purchased pet food maker Tropikal.

  • Riverside’s court reporting deal returns 5.1x
    Amanda Janis- 5 January 2013

    The sale of New Jersey-headquartered Veritext to Investcorp generated a 38% gross IRR for mid-market firm Riverside.

  • CVC pulls out of $1.5bn joint bid for Healthscope
    Aston Tan- 5 January 2013

    KKR is now bidding alone for the Australian hospital operator against a trio comprising Blackstone, TPG and Carlyle.

  • LPs may flood US mid-market with capital
    Christopher Witkowsky- 5 January 2013

    Panelists at a conference in New York Wednesday touted the advantages of the mid-market, but said LP appetite for exposure to the space could lead to ‘mistakes’.

  • Riverside buys Australian medical company
    Aston Tan- 5 January 2013

    The acquisition of an Australian medical evaluation provider is The Riverside Company's second platform investment in Australia, where the firm opened an office in April.